Drug Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Avian Influenza
Indian marketing approval on generic Tamiflu obtained by Cipla
March 24th, 2006
Cipla has received marketing approval from the Drug Controller General of India to market the generic version of Tamiflu, the bird-flu drug globally marketed by Roche. A senior representative with Cipla confirmed the development and said the chemically similar drug would be priced lower than the branded Tamiflu. An analyst tracking the segment said Cipla would be able to market the drug in India, as there is no patent on the drug there, according to the company. Patent applications on the drug are pending in the mailbox of the Patent Controller's office. Cipla also says it has export orders on generic Tamiflu in its kitty and the...
Source: Drug Week (2006-03-24)
|
